Surfactant as recovered by alveolar wash from healthy adult separated into large aggregate forms (LA) and small ag-animals is a mixture of surfactant phospholipids and proteins in gregate forms (SA) by centrifugation at 40 000 x g. LA multiple aggregate sizes (I). Several investigators have shown contain SP-A and the surfactant lipophilic proteins SP-B that LA and SA of surfactant separated by centrifugation have and SP-C and are surface-active in vitro, whereas SA lack different biochemical and morphologic characteristics and difthe surfactant proteins and have poor surface properties. ferent surface properties in vitro (1-4). LA of surfactant comPremature rabbits were treated with LA or SA and venti-posed of mainly tubular myelin and large multilamellar vesicles lated to evaluate the effects of LA and SA in vivo. There are surface active, whereas the SA are much less surface active. were dose-response effects of LA at doses between 10 and There are no differences in phospholipid composition of the 50 mg total lipidlkg: dynamic compliances increased from different aggregate forms; however, the surfactant-specific pro-0.4 to 0.8 mL/cm HzO/kg and pressure-volume curves tein content (SP-A, -B, and -C) differs between the aggregate improved significantly, whereas SA did not improve any of forms of surfactant. LA contain most of the surfactant proteins the measurements at any dose. Organic solvent extracts of recovered by alveolar wash, whereas SA contain very little sur-SA made up into LA also did not improve in vivo function. factant protein (2). Recently, several groups demonstrated that When 1.5% SP-B and SP-C isolated from calf surfactant surfactant lipophilic proteins SP-B and SP-C are essential comwas added to organic solvent extracts of SA, the surfactant ponents of surfactant extracts or phospholipid mixtures for the had good in vitro surface properties and increased maxi-achievement of low surface tensions and rapid adsorption (5-mum lung volumes. However, this surfactant did not im-10). However, in vitro properties do not necessarily correlate well prove dynamic compliances or lung stability on pressure-with in vivo responses ( 1 1). Therefore, we asked what the effects volume curves. Because the lipids from SA seemed to limit of LA and SA surfactant were when tested in vivo in preterm the compliance response, we tried to identify differences in ventilated rabbits. We also wanted to know if any differences lipids from LA and SA. Phospholipids from SA reconsti-might depend on the aggregate forms, the presence of SP-B and tuted with SP-BC did not function well in vivo, whereas SP-C, or other factors. phospholipids from LA with SP-BC were similar to LA surfactant. The neutral lipid fractions from LA or SA did not contribute very much to or inhibit function. Fatty acid
composition of the phospholipids and phosphatidylcholine
Recovery of LA or SA surfactant. New Zealand White rabbits from LA and SA were not remarkably different. We con-(1.5-2.0 kg) were killed with pentobarbital. The aorta of each clude that subtle compositional differences in the phospho-rabbit was cut, the chest was opened, and a tube was tied in the lipids or difficulties with reconstriction of the lipids with trachea. The lungs were filled with room temperature 0.15 M SP-BC prevents in vivo function of SA surfactant. (Pediatr NaC1, which was then withdrawn with a syringe. This procedure Res 27: 592-598,1990) was repeated three times and the three alveolar washes were pooled. Alveolar washes were centrifuged at 140 x g for 10 min
Abbreviations in a Somall SS-34 rotor to remove cellular debris. The supernatant was centrifuged at 40 000 x g for 15 min (12) . The super-LA, large aggregate surfactant natant from the 40 000 x g centrifugation was concentrated SA, small aggregate surfactant approximately 150-to 200-fold by ultrafiltration (Diaflo, SP-A, surfactant protein-A XM300, Amicon Corp., Danvers, MA) and used as SA surfac-SP-B, sufactant protein-B tant. The pellet was resuspended with 0.15 M NaCl and again SP-C, surfactant protein-C centrifuged at 40 000 x g for 15 min in a Sorvall SS-34 rotor SP-BC, mixture of SP-B and SP-C (Dupont Instruments, Wilmington, DE) over 1 M sucrose in LE-LA, lipid extract of large aggregate surfactant 0.15 M NaCI. The LA then was collected from the interface of LE-SA, lipid extract of small aggregate surfactant 0.15 M NaCl and sucrose, diluted with 0.075 M NaCl and DPPC, dipalmitoylphosphatidylcholine centrifuged at 40 000 x g for 20 min in a SS-34 rotor. The pellet, PG, phosphatidylglycerol resuspended in 0.075 M NaCI, was then used for animal testing PA, palmitic acid because suspending fluid of lower ionic strength promoted fluid adsorption in adult rabbit lung (13) . The concentrations of LA and SA were adjusted to 7.7 mg total lipid/mL before use.
Change of aggregate size of organic solvent extracts of LA and SA. The lipids of LA and SA were extracted with chloro-trifuged at 40 000 x g for 15 min, and the material that sedimented was resuspended in 0.075 M NaCl to a concentration of 7.7 mg lipid/mL. The final suspensions of both fractions then only contained sedimentable aggregates that contained 9 1 % of the original LE-LA and 86% of the LE-SA.
Isolation of SP-BC. Surfactant isolated from alveolar washes of newborn calves as previously described (1 4) was extracted two times with chloroform:methanol (2: 1, vol/vol). The chloroform phase was dried and resuspended with a small volume of chloroform:methanol(2: 1, vol/vol) from which SP-B and SP-C were then isolated together according to Takahashi and Fujiwara (1 5).
Solutions containing approximately 400 mg total lipid were applied to a 2.5 x 100 cm column of Sephadex LH-20 (Pharmacia Fine Chemicals Ltd., Uppsala, Sweden) that had been equilibrated with chloroform:methanol (2: 1, vol/vol). The proteins were then eluted with the same solvent at a flow rate of 0.34 mL/min at room temperature. The effluent was monitored at 280 nm, and fractions from the first 213 of the first peak that separated protein from phospholipids were combined and analyzed for protein in 1% SDS by the technique of Lowry et al. (16) Pressure-volume curves. The rabbits were temperature-controlled at 37"C, and pressure was increased from 0 to 35 cm H20 by 5-cm HzO increments with maintenance of the pressure for 30 s at each level. Pressure then was lowered at the same rate, and volumes at all pressures were recorded. The measured volumes were corrected for air compression of the system. After one pressure-volume cycle, the chests were opened and alveolar washes were camed out with 0.15 M NaCl (19) . The alveolar wash procedure was repeated five times, the washes were pooled and the total volume was measured. These alveolar washes were used for the measurements of total phospholipid and total protein. Analytic procedures. Aliquots of the different surfactants were extracted with chloroform:methanol (2: 1, vol/vol) and the lipid extracts were assayed for phosphorus according to Bartlett (20) . Total protein in the alveolar washes was measured according to Lowry et al. (16) . The phospholipid composition of the LE-LA and LE-SA was measured after two-dimensional thin-layer chromatography of the lipid extracts (2 1). The phospholipids were identified in iodine vapor, and phosphorus content of the phospholipids was measured. Data analysis. All values are expressed as means k SEM.
Between-group comparisons were by one-way analysis of variance followed by the Student-Newman-Keuls multiple comparison procedure. The t test was used for comparisons versus control values.
RESULTS

Characteristics of surfactants. After centrifugation of alveolar
washes of adult rabbits, 43% of the phospholipid was recovered as LA and 57% as SA. Total protein in alveolar washes measured according to Lowry et al. (16) was 0.6-0.8 mg/kg for LA and 6.9-9.2 mg/kg for SA. The protein to phospholipid ratio for the LA was 0.24 mg protein/mg phospholipid, whereas there was a higher ratio of 2.02 mg protein/mg phospholipid for SA. The phospholipid compositions of LA and SA fractions were similar, although there was an increase in lysophosphatidylcholine from 1 % in LA to 4% in small SA (Table I ). The SP-BC isolated for the reconstituted surfactant gave one wide band at about 6 kD by SDS-polyacrylamide gel electrophoresis and other protein bands were not seen. Fatty acid composition. The fatty acid composition of total phospholipids were measured for pooled samples of SA and LA and for phosphatidylcholine isolated from these fractions ( Table  2 ). There were no striking differences in fatty acid compositions for either the total phospholipids or phosphatidylcholines from the LA and SA surfactants. The resulting total percent saturated fatty acids was 66% for SA and 7 1 % for LA phospholipids and 77% for SA and 74% for LA phosphatidylcholine. Surface tensions. Minimum surface tensions for LA, LE-SA with SP-BC, and Survanta were lower than for the other surfactants ( p < 0.01, Table 3 ). Although the lipid extraction procedure removed SP-A from the surfactant, LE-LA still lowered the Compliance improved with increasing dose of LA, whereas there was no improvement in the animals given SA at any dose (Fig.  1A) . The dose-response relationships for lung volume at 35 cm H 2 0 pressure measured from pressure-volume curves were similar to the changes seen in dynamic compliance (Fig. 1 B) . Twenty and 50 mg LA significantly increased volume relative to control rabbits ( p < 0.01). There was no change from control in SAtreated animals.
Organic solvent-extracted LA and SA surfactant. The LA and SA were extracted and resuspended to form large multilamellar aggregates, defined by sedimentation at 40 000 X g. The surfactant suspensions were tested at doses of 50 mg total lipid/kg in ventilated preterm rabbits. Dynamic compliance values at 15 min were the same for rabbits treated with SA or LE-SA as for the control animals ( Fig. 2A) . The effect on compliance of the LE-LA was intermediate between that of the LA and the controls, indicating an adverse effect of the extraction and resuspension procedure. SA and LE-SA did not improve the pressure-volume curves (Fig. 2B) . The volume at 35 cm H 2 0 was significantly decreased for LE-SA relative to SA ( p < 0.01). The effect of organic solvent extraction of LA on the volume at 35 cm H 2 0 was to modestly but significantly reduce the volume relative to LA; however, the pressure-volume curves for both LA and LE-LA demonstrated much more volume at 5 or 10 cm H 2 0 than did the other surfactants ( p < 0.01).
Effects of addition of SP-BC. LE-SA with SP-BC and DPPC + P C + PA with SP-BC did not improve dynamic compliance after Groups of seven to eight rabbits were studied for each dose of the large or small aggregate surfactant. LA surfactant significantly increased compliances and lung volumes at 20 and 50 mg total lipid/kg relative to both the control and SA (* p < 0.05, ** p < 0.01).
15 min of ventilation, whereas Survanta improved compliance relative to these two surfactants or to the control ( p < 0.0 1 , Fig.   3A ). However, DPPC + PG + PA with SP-BC improved compliance at 5 min of ventilation to values similar to those of Survanta. This initial effect was similar to that found with LA. Lung volumes at 35 cm H 2 0 measured with the pressure-volume curves were the same for the two mixtures with SP-BC and Survanta and were larger than controls ( p < 0.01, Fig. 3B ). However, the lung volumes at 5 or 10 cm H 2 0 on the deflation limbs of the pressure-volume curves differentiated the three surfactants. Suwanta treatments resulted in a more stable lung, whereas the lipid mixture or LE-SA with SP-BC did not stabilize the lungs at low pressures.
Effects of neutral lipids. Organic solvent extracts of LA and SA contained 5-10% by wt neutral lipids. Removal of the neutral lipids from the LE-LA did not significantly alter compliance or volume at 35 cm H 2 0 but did decrease volume at 10 cm H20 ( p < 0.01) (Fig. 4) . The neutral lipids from LE-SA, when added to the phospholipids from LE-LA, did not change the compliance values or the lung volumes at 35 cm H 2 0 but they did improve the lung volumes at 10 cm H20. Removal of neutral lipids from LE-SA did not improve the responses to the phospholipids from LE-SA. Therefore, the neutral lipids from SA were not inhibitory to function. The neutral lipids from LE-LA did not improve the function of the phospholipids from LE-SA. Rather, the addition of the neutral lipids resulted in a decrease in volume at 35 cm H20.
Protein in alveolar washes. The amounts of protein in alveolar washes were different depending on the surfactants used to treat the animals (Fig. 5) . Protein in the animals treated with LA, LE-LA, or Survanta was significantly lower than controls ( p < 0.01).
The animals given SA or LE-SA had about the same amount of protein as controls. The addition of SP-BC did not increase the protein recoveries very much relative to control values.
DISCUSSION
The surfactant secreted from lamellar bodies into the alveolar space exists in several different aggregate forms that have differ- ent biochemical and physiologic properties (1-4) . Large aggregate surfactant containing tubular myelin and large vesicles has SP-A, SP-B, and SP-C, adsorbs to an air-water interface rapidly, and lowers surface tensions to low values. In contrast, small aggregate surfactant composed of small vesicles contains very little of these proteins and adsorbs more slowly. In addition, there is a precursor-product relationship between LA and SA ( 1 , 22) . The morphologic changes from LA to SA accompanying the changes in surfactant protein content and surface properties imply a lifecycle of surfactant in the alveoli. Stevens et al. (23) and Bruni et al. (24) have demonstrated the time course for the appearance of SA in the airspaces of term rabbits after birth. Initially, almost all the alveolar phospholipids were in a large aggregate surfaceactive fraction. The smaller, less surface-active forms appeared over the first hours of life to achieve the ratio comparable to the adult rabbit by 24 h. Similar but more rapid changes were noted for ventilated preterm lambs with and without surfactant treatment (12, 25) . The function of these surfactant fractions is assumed to be abnormal in vivo because of the lack of surfactant control SA-PL SA-PL LA-PL LA-PL LE-LA +V\-NL +SA-NL Fig. 4 . Dynamic compliances ( A ) and effects on volume at 10 and 35 cm H 2 0 (B) for mixtures of phospholipids (PL) and neutral lipids (NL) from LA or SA surfactants for groups of six to eight rabbits. SP-BC was added at 1.5% by wt to all mixtures except the organic solventextracted large aggregates (LE-LA). Large aggregate phospholipid (LA-PL) and LA-PL plus small aggregate neutral lipid (SA-NL) resulted in compliances that were equivalent to LE-LA and significantly better than control (*p < 0.05, **p < 0.01). Significant differences for values for lung volumes at 35 cm H 2 0 were as follows: 6, 5, and 4 > 3 and 1; 6 > 2; and 2 > 1 ( p < 0.01). Significant differences for volumes at 10 cm H 2 0 were 6 > 1, 2, 3, and 4 and 5 > 1 (p < 0.01).
., proteins (2), but this has not been evaluated. Therefore, the purpose for these experiments was to test the effect of large and small aggregate surfactant subfractions in a surfactant deficiency model, the preterm ventilated rabbit.
The large aggregate surfactant fraction isolated from rabbit alveolar washes was recovered in a manner similar to that used for the preparation of natural sufactant for experimental use (14).
There was a dose-response effect for compliance in the animals treated with the LA fraction. The response at 50 mg total lipid/ kg was higher than that at 20 mg total lipid/kg (p < 0.01), whereas the dose-response effect for lung volume at 35 cm Hz0 pressure was maximal at 20 mg total lipid/kg, and there was no significant effect of increasing the dose to 50 mg total lipid/kg.
These observations indicate that static maximal distensibility of alveoli was accomplished at a dose of exogenous surfactant that was not optimal to achieve a good compliance in vivo. Therefore, we are left with the primary difference between the function of the LA and SA possibly being the phospholipids. Phospholipid composition was similar in LA and SA (Table 1) . The fatty acid composition of phosphatidylcholine from LA and SA also was quite similar and comparable to that previously reported for surfactant from dog lungs (37) or rabbit lungs (2 1). There was a modest increase in unsaturation in the total phospholipid fraction from SA. King (38) showed that lipid mixtures that contained both saturated phosphatidylcholine and dipalmitoylphosphatidylglycerol were bound to SP-A, and small decreases in the disaturated content resulted in decreased protein binding. It is possible that the change in the aggregate form of surfactant from large to small was accompanied by not only the loss of SP-A and SP-BC but also a small increase in unsaturated phospholipids that altered the interaction between SP-BC and the lipids. The increased lysophosphatidylcholine content of SA could also impact function as lysophosphatidylcholine is known to injure the lung and interfere with surface properties (39). An alternative possibility is that the SP-BC proteins were damaged during isolation and/or that the reformulation did not effectively reconstitute a surfactant from the SA lipids. The reconstitution of LE-SA with SP-BC did improve lung volumes, and the isolated proteins did enhance the in vivo function of the synthetic lipid mixture. Nevertheless, these mixing experiments could not definitively distinguish between subtle differences in the phospholipids of LA and SA, or complex lipid-protein interactions that altered function.
In summary, LA from the airspaces of healthy adult rabbits could be organic solvent-extracted and neutral lipid-depleted without much change in in vivo properties. SA did not improve lung function from that of control rabbits, and changes in aggregate size, addition of SP-BC, or removal of neutral lipids did not appreciably improve function, indicating that the phospholipids may have been limiting the reconstitution of the in vivo effects. Our studies demonstrate that there are complex interactions between lipids and proteins that are required for optimal function in the surfactant-deficient preterm lung. 
Announcements Meeting Announcement
The Society for Behavioral Pediatrics will conduct its 8th Annual Scientific Meeting on September [16] [17] 1990 at the Westin Hotel in Denver, CO. The theme of this meeting will be "Behavioral Pediatrics and Education: A Vital Interface." The 1990 SBP Lectureship Address will be delivered by Bettye M. Caldwell, Ph.D. For further information and registration forms, please contact Ms. Noreen Spota at (2 15) 248-9 168.
Charles E. Culpeper Foundation Scholarships in Medical Science
The Charles E. Culpeper Foundation is currently accepting applications for its 199 1 Scholarships in Medical Science Program designed to support the career development of academic physicians.
Up to three awards of $100,000 per year for 3 y will be made to United States medical schools on behalf of candidates who are U.S. citizens, who have received their M.D. degree from a U.S. medical school in 1982 or later, and who are judged worthy of support by virtue of the quality of their research proposals. All scientific research relevant to human health is eligible for consideration. No institution may nominate more than one candidate.
In selecting awardees, emphasis will be on identifying young physicians with clear potential for making substantial contributions to science as academic physicians. Since January 1988, nine physicians have been selected as Charles E. Culpeper Foundation Medical Scholars, three each in the years 1988, 1989, and 1990 .
Deadline for applications is August 15, 1990 . Awards will be announced by January 15, 199 1 for activation on or about July 1, 199 1. Application forms and instructions may be obtained by contacting the Charles E. Culpeper Foundation at 10 Stamford Forum, Stamford, CT 0690 1.
